Dong-Yeop Shin, M.D., Ph.D.^1*, Sung-Soo Yoon, M.D., Ph.D.¹, Junshik Hong, M.D., Ph.D.¹, Je-Hwan Lee, MD, PhD², Jun-Ho Jang, MD., PhD.³, June-won Cheong, MD, PhD⁴, Ho-Jin Shin, MD^5*, Jeong-Ok Lee, MD⁶, Yoo Jin Lee, MD., PhD.⁷, Jae-Sook Ahn, MD, PhD⁸, Byoung-Sik Cho, MD, PhD^9*, Hee-Je Kim¹⁰, Joseph Clarey, MBBS FRACP FRCPA^11*, Gi-Jun Sung, PhD^12*, Jeejin Im, MS^12*, Ky-Youb Nam, PhD¹³, June Han, PhD^12*, Kyu-Tae Kim, PhD^12*, JeongHyeok Yoon, PhD^12*, Bao Nguyen^14*, Li Li, MD^14* and Donald Small, MD, PhD¹⁴

¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
⁵Department of Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)
⁶Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
⁷Division of Hemato-oncology, Department of Internal Medicine, Ulsan University Hospital, Uisan, Korea, Republic of (South)
⁸Chonnam National University Hwasun Hospital, Jeollanam-Do, South Korea
⁹Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
¹⁰Department of Hematology, Seoul St. Mary's Hospital, Seoul, Korea, Republic of (South)
¹¹ICON cancer centre, North Mackay, Australia
¹²Pharos iBio Co., Ltd., Anyang, Korea, Republic of (South)
¹³Pharos iBio Co., Ltd., Anyang, South Korea
¹⁴Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

Sylvain Garciaz, MD^1*, Pierre Bories, MD, PhD^2*, Jean-Marie Boher^3*, Marie Anne Hospital, MD, PhD^4*, Christian Récher, MD, PhD⁵, Colombe Saillard, MD^4*, Yosr Hicheri, MD^4*, Renato Monteiro^6*, Olivier Hermine, MD, PhD⁷, Pierre Launay, PhD^6* and Norbert Vey, MD⁸

¹Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France; Centre National de la Recherche Scientifique, UMR7258, Marseille, France; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille, France, Marseille, France
²hematologie, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
³Institut Paoli Calmettes, Biostatistics Unit, Marseille, France
⁴Department of Hematology, Institut Paoli-Calmettes, Marseille, France
⁵Hematology Department, CHU deToulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁶Inatherys, Evry, France
⁷Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
⁸Department of Hematology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM, Marseille, France

Betul Oran, MD, MS¹, David Marin, MD¹, Qaiser Bashir, MD¹, Sairah Ahmed, MD², Amanda L. Olson, MD³, Uday Popat, MD¹, Partow Kebriaei, MD⁴, Elizabeth J. Shpall, MD¹, Vinay Jain, MD, MBBS⁵ and Richard E. Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴M.D. Anderson Cancer Center, Houston, TX
⁵Arog Pharmaceuticals, Inc., Dallas, TX

Cristina Tognon, PhD^1*, Shikha Mishra, MS^1*, Andy Kaempf, MS^2*, Byung Park, PhD^2*, Sunil K Joshi, MD PhD^1,3, Ariane Huang, BS^1*, Stephen E. Kurtz, PhD^1*, Luca Sax, BSc^1*, Christopher A. Eide^1*, Kara Johnson, BSc^1*, Rachel Mahoney, BSc^1*, Michael James Lue, MS^1*, Nicole Tong, BSc^1*, Lisa Guiducci^1*, Tara Lundberg Willians, BSc, MBA^1*, Emma Indira Solanki, MSc^1*, Rachel J. Cook, MD, MS⁴, Jessica T. Leonard, MD⁵, Curtis A Lachowiez, MD¹, Gabrielle Meyers, MD^1*, Jennifer N. Saultz, DO¹, Elie Traer, MD, PhD¹, Jeffrey W. Tyner, PhD¹, Uma Borate, MD⁶ and Ronan T. Swords, MD, PhD, FRCP, FRCPath¹

¹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
²Knight Cancer Institute, Biostatistics Shared Resource, Oregon Health & Science University, Portland, OR
³Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁴Oregon Health & Science University, Portland, OR
⁵Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁶The Ohio State University, Columbus, OH

Amir T. Fathi^1*, Aleksandra Filipovic, MD^2*, Keri Maher, DO³, Dale G Schaar, MD, PhD⁴, Rabin Niroula, MBBS⁵, Joseph J. Maly^6*, Deepa Jaykumar^7*, Noah Merin, MD, PhD⁸, Jay Yang, MD⁹, Jorge R. Galvez Silva, M.D.¹⁰, Varun Gang^11*, Taylor Meeks, BSc^11*, Christopher Korth^2* and Guenther Koehne, MD, PhD¹²

¹Massachusetts General Hospital, Boston
²PureTech Health, Boston, MA
³Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ
⁴Robert Wood Johnson Med. School The Cancer Inst. of NJ (CINJ), New Brunswick, NJ
⁵Legorreta Cancer Center, Lifespan Cancer Institute Providence, Providence, RI
⁶Norton Cancer Institute, Louisville, KY
⁷University of California Irvine Medical Center, Orange, CA, Orange
⁸Hematology and Cellular Therapy, Cedars-Sinai Medical Center, Los Angeles, CA
⁹Karmanos Cancer Institute, Detroit, MI
¹⁰Nicklaus Children's Hospital, Miami, FL
¹¹PureTech health, Boston
¹²Baptist Health South Florida, Miami Cancer Institute, Miami, FL

David Taussig, PhD, MRCP, FRCPath¹, David C. de Leeuw, MD, PhD^2*, Mojca Jongen-Lavrencic, MD, PhD³, Jenny O'Nions^4*, Thinzar Koko, MRCP, FRCPath⁵, Emma Searle^6*, Geoff Fisher, PhD^7*, Sue Brook, PhD, MRCP, FFPM^7*, Hendrik-Tobias Arkenau, MD, PhD, FRCP^7*, Ayan Aden Yusuf^7* and Peter T. Tan, MBBS⁸

¹The Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
²Amsterdam University Medical Center, Amsterdam, Netherlands
³Erasmus University Medical Center, Rotterdam, Netherlands
⁴University College London Hospital NHS Foundation Trust, London, United Kingdom
⁵Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom
⁶The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom
⁷Ellipses Pharma, London, United Kingdom
⁸Royal Perth Hospital, Perth, Australia

Ming Hong, MD, PhD^1*, Wenjie Liu, M.D.;Ph.D.^1*, Qian Sun, M.D.;Ph.D.^1*, Jianyong Li, MD² and Sixuan Qian^3*

¹Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Jiangsu Province Hospital, Nanjing, China

Sandra Cohen, MD¹, Nadia M. Bambace, MD², Lea Bernard, MD¹, Imran Ahmad, MD¹, Jean Roy, MD¹, Sylvie Lachance, MD¹, Jean-Sebastien Delisle, MD, PhD³, Thomas L. Kiss, MD¹, Denis-Claude Roy, MD³, Olivier Veilleux, MD¹ and Guy Sauvageau, MD/PhD⁴

¹Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, QC, Canada
²Baptist Health South Florida, Miami Cancer Institute, Miami, FL
³Hematology-Oncology and Cell Therapy University Institute, Hôpital Maisonneuve-Rosemont Research Center, Montreal, QC, Canada
⁴Institut de recherche en Immunologie et Cancer, Université de Montréal, Montreal, QC, Canada

Brian A. Jonas, MD, PhD¹, Zarir E. Karanjawala, MD, PhD,^2*, Laura Molnar, CCRP^3*, Ashley Linh Dang-Chu, CCRP^3*, Mehrdad Abedi, MD^1*, Naseem S. Esteghamat, MD¹, Aaron S. Rosenberg, MD¹, Francisco Andres Socola, MD¹, Lihong Qi, PhD^4* and Joseph M. Tuscano, MD¹

¹Department of Internal Medicine, Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
²Department of Pathology, University of California Davis School of Medicine, Sacramento, CA
³Office of Clinical Research, UC Davis Comprehensive Cancer Center, Sacramento, CA
⁴Division of Biostatistics, University of California Davis, Davis, CA

Wenbing Duan^1*, Chunkang Chang, MD^2*, Zhiguo Wang^3*, Hongbing Ma^4*, Min Ouyang^5*, Xingli Zhao^6*, Lifan Tu^7*, Guodong Wu^8*, Xunqiang Wang^8*, Xiao Jun Huang⁹ and Hao Jiang^10*

¹Department of Hematology, Peking University People's Hospital, Beijing, China
²Hematology department, Shanghai Sixth People's Hospital, Shanghai Jiaotong University school of Medicine, Shanghai, China
³Harbin The First Hospital, Harbin, CHN
⁴West China Hospital, Sichuan University, Chengdu, China
⁵Peking University international Hospital, Beijing, China
⁶Department of Hematology, Oncology Center, Tianjin People's Hospital, No. 190 jieyuan Road, Hongqiao District,, Tianjin, China
⁷Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, AL, China
⁸Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Nanjing, China
⁹Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
¹⁰Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China